Showing results (201-210 of 246) with videos related to

Sort By:
Pageof 25
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 22, 2026
[Association of triglyceride glucose index and its combination with obesity indicators with metabolic dysfunction-associated steatotic liver disease in community residents of Songjiang District, Shanghai]L X Yang, J Li, J G Yu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 24, 2023
[Association between sedentary behavior and force expiratory volume in 1 second reduction in middle-aged and elderly adults in communities]S S Hou, Y L Wu, W Luo, et al.
British Journal of Cancer|June 16, 2005
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patientsG-B Qiao, Y-L Wu, X-N Yang, et al.
Biomedical and Environmental Sciences : BES|September 1, 1990
Studies of the genotoxicity of glycidyl methacrylate (GMA)D Y Xie, W Zhang, L F Cao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2012
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803)Y-L Wu, C Zhou, Y Cheng, et al.
Parasitology Research|May 26, 2017
Molecular characterization of Blastocystis sp. in captive wild animals in Qinling MountainsG H Zhao, X F Hu, T L Liu, et al.
Parasitology Research|December 6, 2017
Correction to: Molecular characterization of Blastocystis sp. in captive wild animals in Qinling MountainsG H Zhao, X F Hu, T L Liu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 5, 2013
Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) studyC C Zhou, C X Bai, Z Z Guan, et al.
Cancer Gene Therapy|March 1, 2014
Lower Ras expression as an independent predictor of patient outcomes in lung cancer treated with bevacizumab plus chemotherapyS J An, Y S Huang, Z H Chen, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|March 1, 1993
A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiencyR G Chen, Y N Shen, J Yei, et al.
Pageof 25